Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Noninfectious Uveitis

NCT03207815 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT03207815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Noninfectious Uveitis
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Terminated
Start date
July 26, 2017
Completion date
April 22, 2021
Enrollment
74 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

noninfectious uveitis